Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C5H12NO5P |
| Molecular Weight | 197.1262 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
N[C@H](CCCP(O)(O)=O)C(O)=O
InChI
InChIKey=VOROEQBFPPIACJ-SCSAIBSYSA-N
InChI=1S/C5H12NO5P/c6-4(5(7)8)2-1-3-12(9,10)11/h4H,1-3,6H2,(H,7,8)(H2,9,10,11)/t4-/m1/s1
| Molecular Formula | C5H12NO5P |
| Molecular Weight | 197.1262 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 19:23:44 GMT 2023
by
admin
on
Sat Dec 16 19:23:44 GMT 2023
|
| Record UNII |
CD39X2NL7F
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WIKIPEDIA |
NMDA receptor antagonist
Created by
admin on Sat Dec 16 19:23:44 GMT 2023 , Edited by admin on Sat Dec 16 19:23:44 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID201000239
Created by
admin on Sat Dec 16 19:23:44 GMT 2023 , Edited by admin on Sat Dec 16 19:23:44 GMT 2023
|
PRIMARY | |||
|
79055-68-8
Created by
admin on Sat Dec 16 19:23:44 GMT 2023 , Edited by admin on Sat Dec 16 19:23:44 GMT 2023
|
PRIMARY | |||
|
CD39X2NL7F
Created by
admin on Sat Dec 16 19:23:44 GMT 2023 , Edited by admin on Sat Dec 16 19:23:44 GMT 2023
|
PRIMARY | |||
|
135342
Created by
admin on Sat Dec 16 19:23:44 GMT 2023 , Edited by admin on Sat Dec 16 19:23:44 GMT 2023
|
PRIMARY | |||
|
AP5
Created by
admin on Sat Dec 16 19:23:44 GMT 2023 , Edited by admin on Sat Dec 16 19:23:44 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
RACEMATE -> ACTIVE ENANTIOMER |
|
||
|
TARGET -> INHIBITOR |
Blocks glutamate binding.
COMPETITIVE INHIBITOR
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
|
